Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Peripheral Blood Stem Cells

Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: experience of İbni Sina Hospital

Bone Marrow Transplantation volume 25, pages 1229–1232 (2000)Cite this article

Abstract

Fifty-three patients with standard risk leukemia who underwent allogeneic peripheral blood stem cell transplantation (alloPBSCT) from their HLA-identical siblings were analyzed for engraftment, incidence and severity of GVHD, and relapse rate. Standard risk leukemia was defined as AML in first complete remission or CML in first chronic phase within the first year after diagnosis. The median age was 34.5 years (range 13–47). Stem cells were mobilized by using 10 μg/kg G-CSF subcutaneously for 5 days. A median of 5.7 (2.1–21.4) × 106/kg CD34+ cells was collected over a median of 2 (range 1–5) apheresis procedures. cyclosporin a (csa) plus short-course mtx were used for gvhd prophylaxis. recovery to granulocytes >0.5 × 109/l and platelets >20 × 109/l occurred at a median of day +13 (range 8–32) and +13 (range 8–51), respectively. Day +100 transplant-related mortality was 13.2% (7/53). Acute GVHD occurred in 20 of 49 (41%) evaluable patients and only six (12.3%) of them had severe disease (grade III-IV). Chronic GVHD occurred in 30 of 42 (71.4%) evaluable patients. Relapse rate at 2 years was 7.5%. The median overall and leukemia-free survivals were 22 (4–44) and 20 (3–44) months, respectively. Estimated 4 year leukemia-free and overall survival rates were 60% and 62%, respectively. In conclusion, alloPBSCT in standard risk leukemia seems to be associated with a low relapse rate and no increased risk of acute GVHD, but there is a trend for higher incidence of cGVHD. Bone Marrow Transplantation (2000) 25, 1229–1232.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Kessinger A, Smith DM, Strandjord SE et al. Allogeneic transplantation of blood-derived, T cell-depleted hematopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia Bone Marrow Transplant 1989 4: 643–646

    CAS  PubMed  Google Scholar 

  2. Russell NH, Hunter A, Rogers S et al. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation (letter) Lancet 1993 341: 1482–1493

    Article  CAS  Google Scholar 

  3. Dreger P, Haferlach T, Eckstein V et al. G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft Br J Haematol 1994 87: 609–613

    Article  CAS  Google Scholar 

  4. Tjnnfjord GE, Steen R, Evensen SA et al. Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor Blood 1994 84: 2795–2801

    Google Scholar 

  5. Bensinger WI, Price TH, Dale DC . The effects of daily recombinant human granulocyte colony stimulating factor administration on normal granulocyte donors undergoing leukapheresis Blood 1993 81: 1883–1888

    CAS  PubMed  Google Scholar 

  6. Bensinger WI, Weaver CH, Applebaum FR et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor Blood 1995 85: 1655–1658

    CAS  PubMed  Google Scholar 

  7. Schmitz N, Dreger P, Suttorp M et al. Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by Filgrastim (G-CSF) Blood 1995 85: 1666–1672

    CAS  PubMed  Google Scholar 

  8. Körbling M, Przepiorka D, Huh YO et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts Blood 1995 85: 1659–1665

    PubMed  Google Scholar 

  9. Bensinger WI, Clift R, Martin P et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison withmarrow transplantation Blood 1996 88: 2794–2800

    CAS  PubMed  Google Scholar 

  10. Hoglund H, Ringden O, Remberger M et al. Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using blood stem cells from related and unrelated donors, compared to bone marrow Bone Marrow Transplant 1998 22: 131–136

    Article  Google Scholar 

  11. Üstün C, Arslan Ö, Beksaç M et al. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center, a focus on the incidence of GVHD and relapse Biol Blood Marrow Transplant 1999 5: 28–35

    Article  Google Scholar 

  12. Bensinger WI, Clift RA, Anasetti C et al. Transplantation of allogeneic peripheral stem cells mobilized by recombinant human granulocyte colony stimulating factor Stem Cells 1995 14: 90–105

    Article  Google Scholar 

  13. Koç H, Gürman G, Arslan Ö et al. Is there an increased risk of graft versus host disease after allogeneic peripheral blood stem cell transplantation Blood 1996 88: 2362–2364

    PubMed  Google Scholar 

  14. Urbano-Ispizua A, Garcia-Conde J, Brunet S et al. High incidence of chronic graft versus host disease (GVHD) after allogeneic peripheral blood progenitor cell transplantation (allo-PBPCT) from matched related donors Blood 1996 88: (Suppl.1) 617 (Abstr.2455)

    Google Scholar 

  15. Garcia-Conde J, Martin-Gaitero MJ, Arbona C et al. High frequency of chronic graft versus host disease (GVHD) associated with unmodified allogeneic peripheral blood progenitor cell transplantation (alloPBPCT). Preliminary results of allogeneic CD34+ selected cell PBPCT Blood 1996 88: (Suppl.1) 261 (Abstr.1031)

    Google Scholar 

  16. Majolino I, Scime R, Cavallaro AM et al. Allogeneic PBSC transplantation: report from the Palermo Center Blood 1996 88: (Suppl.1) 276 (Abstr.3830)

    Google Scholar 

  17. Azevedo AM, Correa MEP, Vigorito AC et al. Chronic graft versus host disease after allogeneic transplants with peripheral blood stem cells or bone marrow: a comparative study Blood 1996 88: (Suppl.1) 273 (Abstr.3818)

    Google Scholar 

  18. Goldman JM, Schmitz N, Niethammer D et al. for the Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe in 1998 Bone Marrow Transplant 1998 21: 1–7

    Article  CAS  Google Scholar 

  19. Storek J, Gooley T, Siadak M et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus host disease Blood 1997 90: 4705–4709

    CAS  PubMed  Google Scholar 

  20. Kaplan EL, Meier P . Nonparametric estimation from incomplete observations J Am Stat Assoc 1958 53: 457–481

    Article  Google Scholar 

  21. Arslan Ö, Üstün C, Arat M et al. Allogeneic peripheral stem cell transplantation in acute nonlymphoblastic leukemia Hematol Oncol 1998 16: 155–162

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology-Oncology, Ankara University, Medical School, İbni Sina Hospital, Bone Marrow Transplantation Unit, Ankara, Turkey

    Ö Arslan, HŞ Coşkun, M Arat, H Çelebi, M Özcan, G Gürman, C Üstün, T Demirer, H Akan, O İlhan, N Konuk, M Beksaç, A Uysal & H Koç

Authors
  1. Ö Arslan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. HŞ Coşkun
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Arat
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H Çelebi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M Özcan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G Gürman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. C Üstün
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. T Demirer
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. H Akan
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. O İlhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. N Konuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. M Beksaç
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. A Uysal
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. H Koç
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arslan, Ö., Coşkun, H., Arat, M. et al. Allogeneic peripheral blood stem cell transplantation for standard risk leukemia: experience of İbni Sina Hospital. Bone Marrow Transplant 25, 1229–1232 (2000). https://doi.org/10.1038/sj.bmt.1702414

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702414

Keywords

Search

Advanced search

Quick links